These images were taken at the 2025 American Medical Association (AMA) House of Delegates (HOD) meeting in Chicago. This annual meeting brings together representatives from across the House of Medicine to propose, debate and vote on resolutions that shape AMA policy. Once adopted, these resolutions guide the group's advocacy efforts on healthcare issues—whether in Congress, state legislatures or in formal recommendations to regulatory agencies.
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/stack_views/public/2024-09/istock-1209664264.jpg.webp?itok=MzQCOefT)
